These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 17040752)

  • 21. Screening of cyclic peptide phage libraries identifies ligands that bind streptavidin with high affinities.
    Giebel LB; Cass RT; Milligan DL; Young DC; Arze R; Johnson CR
    Biochemistry; 1995 Nov; 34(47):15430-5. PubMed ID: 7492543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective enrichment and high-throughput screening of phage surface-displayed cDNA libraries from complex allergenic systems.
    Crameri R; Walter G
    Comb Chem High Throughput Screen; 1999 Apr; 2(2):63-72. PubMed ID: 10420976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phage display technology: clinical applications and recent innovations.
    Azzazy HM; Highsmith WE
    Clin Biochem; 2002 Sep; 35(6):425-45. PubMed ID: 12413604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epitope discovery using monoclonal antibodies and phage peptide libraries.
    Yip YL; Ward RL
    Comb Chem High Throughput Screen; 1999 Jun; 2(3):125-38. PubMed ID: 10420967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mimtags: the use of phage display technology to produce novel protein-specific probes.
    Ahmed N; Dhanapala P; Sadli N; Barrow CJ; Suphioglu C
    J Immunol Methods; 2014 Mar; 405():121-9. PubMed ID: 24530568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A combination of in vitro techniques for efficient discovery of functional monoclonal antibodies against human CXC chemokine receptor-2 (CXCR2).
    Boshuizen RS; Marsden C; Turkstra J; Rossant CJ; Slootstra J; Copley C; Schwamborn K
    MAbs; 2014; 6(6):1415-24. PubMed ID: 25484047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A high-throughput platform for population reformatting and mammalian expression of phage display libraries to enable functional screening as full-length IgG.
    Xiao X; Douthwaite JA; Chen Y; Kemp B; Kidd S; Percival-Alwyn J; Smith A; Goode K; Swerdlow B; Lowe D; Wu H; Dall'Acqua WF; Chowdhury PS
    MAbs; 2017; 9(6):996-1006. PubMed ID: 28613102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advance in phage display technology for bioanalysis.
    Tan Y; Tian T; Liu W; Zhu Z; J Yang C
    Biotechnol J; 2016 Jun; 11(6):732-45. PubMed ID: 27061133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selection of peptides targeting the human sperm surface using random peptide phage display identify ligands homologous to ZP3.
    Eidne KA; Henery CC; Aitken RJ
    Biol Reprod; 2000 Nov; 63(5):1396-402. PubMed ID: 11058544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clustering of disulfide-rich peptides provides scaffolds for hit discovery by phage display: application to interleukin-23.
    Barkan DT; Cheng XL; Celino H; Tran TT; Bhandari A; Craik CS; Sali A; Smythe ML
    BMC Bioinformatics; 2016 Nov; 17(1):481. PubMed ID: 27881076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of receptor ligands with phage display peptide libraries.
    Koivunen E; Arap W; Rajotte D; Lahdenranta J; Pasqualini R
    J Nucl Med; 1999 May; 40(5):883-8. PubMed ID: 10319765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phage display--a powerful technique for immunotherapy: 2. Vaccine delivery.
    Bazan J; Całkosiński I; Gamian A
    Hum Vaccin Immunother; 2012 Dec; 8(12):1829-35. PubMed ID: 22906938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phage Display Technology in Biomaterials Engineering: Progress and Opportunities for Applications in Regenerative Medicine.
    Martins IM; Reis RL; Azevedo HS
    ACS Chem Biol; 2016 Nov; 11(11):2962-2980. PubMed ID: 27661443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specific and selective probes for Pseudomonas aeruginosa from phage-displayed random peptide libraries.
    Carnazza S; Foti C; Gioffrè G; Felici F; Guglielmino S
    Biosens Bioelectron; 2008 Feb; 23(7):1137-44. PubMed ID: 18068970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phage-based peptides for pancreatic cancer diagnosis and treatment: alternative approach.
    Li Y; Yang KD; Duan HY; Du YN; Ye JF
    Front Microbiol; 2023; 14():1231503. PubMed ID: 37601380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phage display as a technology delivering on the promise of peptide drug discovery.
    Hamzeh-Mivehroud M; Alizadeh AA; Morris MB; Church WB; Dastmalchi S
    Drug Discov Today; 2013 Dec; 18(23-24):1144-57. PubMed ID: 24051398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Phage display: a new weapon for antiviral research].
    Castel G; Heyd B; Tordo N
    Virologie (Montrouge); 2009 Apr; 13(2):93-102. PubMed ID: 36151640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phage-display methodology for the study of protein-protein interactions: overview.
    Goodyear CS; Silverman GJ
    CSH Protoc; 2008 Aug; 2008():pdb.top48. PubMed ID: 21356898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bacterial display in combinatorial protein engineering.
    Löfblom J
    Biotechnol J; 2011 Sep; 6(9):1115-29. PubMed ID: 21786423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epitope mapping by phage display: random versus gene-fragment libraries.
    Fack F; Hügle-Dörr B; Song D; Queitsch I; Petersen G; Bautz EK
    J Immunol Methods; 1997 Aug; 206(1-2):43-52. PubMed ID: 9328567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.